Skip to content

Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery

Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery: a Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06826742
Enrollment
30
Registered
2025-02-14
Start date
2025-02-12
Completion date
2025-09-23
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Delivery

Keywords

methadone, morphine, intrathecal, cesarean

Brief summary

The purpose of this study is to determine if there is a difference in opioid requirements at 0-48 hours after scheduled cesarean delivery in patients receiving 150 mcg intrathecal morphine compared to 0.2 mg/kg (maximum 20 mg) intravenous methadone.

Interventions

DRUGIntravenous line (IV) Methadone

Subjects will receive standardized spinal anesthesia without intrathecal morphine (intrathecal 1.6-2 mL 0.75% bupivacaine + dextrose, 15 mcg fentanyl) and intravenous methadone (0.2mg/kg total body weight up to max dose of 20 mg, with saline added to make total volume 2 mL) The Intravenous line (IV) methadone will be administered after cord clamping and administration of uterotonics with the dose of medication divided into 4 equal aliquots each administered 5 minutes apart.

DRUGIntrathecal Morphine

Subjects will receive standardized spinal anesthesia with intrathecal morphine 150 micrograms and no methadone (2cc dose of IV normal saline) The Intravenous line (IV) saline will be administered after cord clamping and administration of uterotonics with the dose of medication divided into 4 equal aliquots each administered 5 minutes apart.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* English-speaking * Age over 18 years old * Scheduled cesarean delivery

Exclusion criteria

* Any contraindication to the administration of a spinal technique for anesthesia * History of intolerance or adverse reaction to opioid medications * History of chronic pain, opioid use \>30 OME/day, or substance use disorder * History of obstructive sleep apnea, chronic obstructive pulmonary disease, or respiratory compromise (SpO2 \<92% on room air, or has a pre-existing oxygen requirement) * History of liver or kidney failure * Diagnosis of pre-eclampsia with current pregnancy * Depression requiring more than one medication * Planned use of CSE technique * BMI \>50.0 kg/m2 * ASA status IV, V * No prior history of an ECG demonstrating QTc \> 440ms * Surgical complication requiring conversion to general anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Total opioid consumption24 hours post-delivery, 48 hours post-deliveryTotal opioid consumption of either intrathecal opiate or intravenous methadone at 24-48 hours after delivery.

Secondary

MeasureTime frameDescription
Numeric Rating Scale (NRS) pain score at rest12 hours, 24 hours, 36 hours, 48 hours, 7 daysA Numeric Rating Scale (NRS) for pain is a patient-reported item regarding the level of pain experienced at rest and is measured on a Likert scale from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable.
Numeric Rating Scale (NRS) for movement-evoked pain12 hours, 24 hours, 36 hours, 48 hours, 7 daysA Numeric Rating Scale (NRS) score for movement-evoked pain is a patient-reported item regarding the level of pain experienced with provoking maneuvers such as cough, inspiration/expiration, sitting up, knee flexion, hip flexion, rolling over in bed, and walking. The NRS is measured on a Likert scale from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable.
Obstetric Quality of Recovery-10 (ObsQoR-10) Scoring Tool24 hours, 48 hours, 7 daysThe Obstetric Quality of Recovery-10 (ObsQoR-10), is a patient-reported 10-item questionnaire used to assess quality of recovery following spinal administration of pain medication. Patients rate each recovery item on a scale of 0 to 10, with 0 = worst possible recovery and 10 = best possible recovery. Total score ranges from 0-100 with higher scores indicating a better recovery after childbirth.
Pruritus12 hours, 24 hours, 36 hours, 48 hoursThe severity of pruritus post spinal administration will be patient-reported on a 4-point Likert scale where 0 = none and 3 = severe.
Richmond Agitation Sedation Scale (RASS)12 hours, 24 hours, 36 hours, 48 hoursThe Richmond Agitation Sedation Scale (RASS) will be used to assess the level of alertness and agitated behavior in patients. The patient's level of consciousness and sedation are rated by care provider, ranging from a combative state (+4) to an unarousable state (-5), with a calm and alert score at 0.
Numeric Rating Scale (NRS) for pain in previous 24 hours12 hours, 24 hours, 36 hours, 48 hours, 7 daysA Numeric Rating Scale (NRS) score for highest level of pain is a patient-reported item regarding the level of pain experienced in the last 24 hours. The NRS is measured on a Likert scale from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026